InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Alloway Paul. Director active across 2 companies, notably Homology Medicines, Inc.. In total, 7 filings have been published. Split: 0 buy · 4 sells. Total volume traded: €29k. History available since 9 January 2023. The latest transaction was disclosed on 25 March 2024 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Alloway Paul is a declarant linked to Homology Medicines, Inc. and Q32 Bio Inc. in the 7 filings recorded. The 7 sampled filings, covering the period from 2023-01-04 to 2024-04-23, show sales of EUR 28669 and no purchases.